Dr. Rajeev Tyagi | Immunology | Best Researcher Award

CSIR-Institute of Microbial Technology (IMTECH), India

Author Profile

Early Academic Pursuits:

Rajeev K. Tyagi, Ph.D., began his academic journey with a Bachelor's degree in Biology followed by a Master's degree in Biotechnology from C.C.S University, Meerut, UP, India. He then pursued his Ph.D. in Immunology, Parasitology, and Vaccinology from the prestigious Institute Pasteur in Paris, France, focusing on humanized mouse models for malaria research.

Professional Endeavors:

His professional career spans over 17 years, encompassing various roles in academia, research, and scientific leadership. He has served as an Assistant Professor at Amity Institute of Microbial Technology and Institute of Science, Nirma University, India. Additionally, he held the position of Scientist at the Biosafety Support Unit, Department of Biotechnology, New Delhi, India.

Contributions and Research Focus:

His research interests lie in humanized mouse models, vaccine development, diagnostics, and nano-drug delivery systems in translational biomedical research. He has contributed significantly to understanding host-parasite interactions in malaria, leading to innovative approaches for disease control and treatment. His work spans across national and international collaborations, focusing on cutting-edge technologies and multidisciplinary approaches.

Accolades and Recognition:

Throughout his career, He has been recognized with numerous awards and honors for his outstanding contributions to the field of biomedical research. These include prestigious fellowships such as the Ramalingaswami Fellowship and awards for his research excellence in malaria and medical entomology. His doctoral thesis received high commendation for its quality and contribution to the field.

Impact and Influence:

His research has had a significant impact on advancing our understanding of infectious diseases, particularly malaria, and developing novel strategies for prevention and treatment. His leadership in organizing conferences and workshops has facilitated knowledge exchange and collaboration among researchers globally, further enhancing the impact of his work.

Legacy and Future Contributions:

As a leader in biomedical research, His legacy lies in his dedication to scientific excellence, innovation, and mentorship. He continues to lead cutting-edge research projects and mentor the next generation of scientists, aiming to address global health challenges and improve human health outcomes. His future contributions are poised to further advance our knowledge and capabilities in combating infectious diseases and improving public health worldwide.


A total of  2239 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations            2239
  • h-index              28
  • i10-index           44

Notable Publications 

Adapalene loaded solid lipid nanoparticles gel: an effective approach for acne treatment

Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin

Surface engineered polymeric nanocarriers mediate the delivery of transferrin-methotrexate conjugates for an improved understanding of brain cancer.

Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder (s)

Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis

Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1

Fucose decorated solid-lipid nanocarriers mediate efficient delivery of methotrexate in breast cancer therapeutics

Effective transdermal delivery of methotrexate through nanostructured lipid carriers in an experimentally induced arthritis model

Site specific/targeted delivery of gemcitabine through anisamide anchored chitosan/poly ethylene glycol nanoparticles: an improved understanding of lung cancer therapeutic …

A synergistic approach of adapalene-loaded nanostructured lipid carriers, and vitamin C co-administration for treating acne



Rajeev Tyagi | Immunology | Best Researcher Award

You May Also Like